74
Views
33
CrossRef citations to date
0
Altmetric
Research Article

Microalbuminuria in Diabetic and Hypertensive Patients and the General Population

, , &
Pages 151-158 | Published online: 09 Jul 2009

REFERENCES

  • Eshoj O, Feldt-Rasmussen B, Larsen ML, Mogensen EF. Comparison of overnight, morning and 24-hour urine collections in the assessment of diabetic microalbumi-nuria. Diabetic Med 1987; 4: 531–3.
  • Cohen DL, Close CF, Viberti GC. The variability of overnight urinary albumin excretion in insulin-dependent diabetic and normal subjects. Diabet Med 1987; 4: 437–40.
  • Jensen JS. Intra-individual variation of overnight albu-min excretion in clinically healthy middle aged individ-uals. Clin Chim Acta 1995; 243: 95–9.
  • Mogensen CE, Christensen CK. Predicting diabetic nephropathy in insulin-dependent patients. N Engl J Med 1984; 311: 89–93.
  • Parving H-H, Oxenb011 B, Svendsen P, Christiansen JS, Andersen AR. Early detection of patients at risk of developing diabetic nephropathy. A longitudinal study of urinary albumin excretion. Acta Endocrinol 1982,100: 550–5.
  • Viberti GC, Hill RD, Janet RJ, Argyropoulos A, Mahmud U, Keen H. Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus. Lancet 1982; i: 1430–2.
  • Dineen SF, Gerstein HC. The association of micro-albuminuria and mortality in non-insulin-dependent diabetes mellitus. A systematic overview. Arch Intern Med 1997; 157: 1413–8.
  • Mogensen CE. Microalbuminuria predicts clinical pro-teinuria and early mortality in maturity-onset diabetes. N Engl J Med 1984; 310: 356–60.
  • Cerasola G, Cottone S, Mule G, Nardi E, Mangano MT, Andronico G, et al. Microalbuminuria, renal dysfunction and cardiovascular complication in essential hyperten-sion. J Hypertens 1996; 14: 915–20.
  • Pedrinelli R, Giampietro O, Carmassi F, Melillo E, Dell'Omo G, Catapano G, et al. Microalbuminuria and endothelial dysfunction in essential hypertension. Lancet 1994; 344: 14–8.
  • Pontremoli R, Nicolella C, Viazzi F, Ravera M, Sofia A, Berruti V, et al. Microalbuminuria is an early marker of target organ damage in essential hypertension. Am J Hypertens 1998; 11: 430–8.
  • Yudkin JS, Forrest RD, Jackson CA. Microalbuminuria as predictor of vascular disease in non-diabetic subjects. Islington Diabetes Survey. Lancet 1988; ii: 530–3.
  • Alzaid AA. Microalbuminuria in patients with NIDDM. An overview. Diabetes Care 1996; 19: 79–89.
  • Pontremoli R, Sofia A, Ravera M, Nicolella C, Viazzi F, Tirotta A, et al. Prevalence and clinical correlates of microalbuminuria in essential hypertension. The MA-GIC Study. Microalbuminuria: A Genoa Investigation on Complications. Hypertension 1997; 30: 1135–43.
  • Bigazzi R, Bianchi S, Campese VM, Baldari G. Prevalence of microalbuminuria in a large population of patients with mild to moderate essential hypertension. Nephron 1992; 61: 94–7.
  • Agewall S, Persson B, Samuelsson O, Ljungman S, Herlitz H, Fagerberg B. Microalbuminuria in treated hypertensive men at high risk of coronary disease. J Hum Hypertens 1993; 11: 461–9.
  • Damsgaard EM, FrOland A, JOrgensen OD, Mogensen CE. Microalbuminuria as predictor of increased mortal-ity in elderly people. Br Med J 1990; 300: 297–300.
  • Jensen JS, Feldt-Rasmussen B, Borch-Johnsen K, Jensen G. Urinary albumin excretion in a population based sample of 1011 middle aged non-diabetic subjects. Scand J Clin Lab Invest 1993; 53: 867–72.
  • Haffner SM, Stem MP, Gruber MKK, Hazuda HP, Mitchell BD, Patterson JK. Microalbuminuria. Potential marker for increased cardiovascular risk factors in nondiabetic subjects? Arteriosclerosis 1990; 10: 727–31.
  • Lindeman RD, Romero L, Liang HC, Hundley R, Baumgartner R, Koehler K, et al. Prevalence of pro-teinuria/microalbuminuria in an elderly urban, biethnic community. Geriatr Nephrol Urol 1998; 8: 123–30.
  • Gatling W, Knight C, Mullee MA, Hill RD. Micro-albuminuria in diabetes: a population study of the prevalence and an assessment of three screening tests. Diabet Med 1988; 5: 343–7.
  • Hoogeveen EK, Kostense PJ, Jager A, Heine RJ, Jakobs C, Bouter LM, et al. Serum homocysteine level and protein intake are related to risk of microalbuminuria: the Hoorn Study. Kidney Int 1998; 54: 203–9.
  • Parving H-H. Microalbuminuria in essential hyperten-sion and diabetes mellitus. Hypertension 1996; 14 (Suppl 2): S89–93.
  • Mogensen CE, Keane WF, Bennett PH, Jerums G, Parving H-H, Passa P, et al. Prevention of diabetic renal disease with special reference to microalbuminuria. Lancet 1995; 346: 1080–4.
  • Phillipou G, Phillips PJ. Variability of urinary albumin excretion in patients with microalbuminuria. Diabetes Care 1994; 17: 425–7.
  • Langhammer A, Johnsen R, Holmen J, Gulsvik A, Bjermer L. Cigarette smoking gives more respiratory symptoms among women than among men. The Nord-Trøndelag Health Study (HUNT). J Epidemiol Commu-nity Health 2000; 54: 917–22.
  • Gerber LM, Johnston K, Alderman MH. Assessment of a new dipstick test in screening for microalbuminuria in patients with hypertension. Am J Hypertens 1998; 11: 1321–7.
  • Jensen JS, Clausen P, Borch-Johnsen K, Jensen G, Feldt-Rasmussen B. Detecting microalbuminuria by urinary albumin/creatinine concentration ratio. Nephrol Dial Transplant 1997; 12 (Suppl 2): 6–9.
  • Bakker AJ. Detection of microalbuminuria. Receiver operating characteristic curve analysis favors albumin-to-creatinine ratio over albumin concentration. Diabetes Care 1999; 22: 307–13.
  • Borch-Johnsen K, Feldt-Rasmussen B, Strandgaard S, Schroll M, Jensen JS. Urinary albumin excretion. An independent predictor of ischemic heart disease. Arterio-scler Thromb Vasc Biol 1999,19: 1992–7.
  • Palatini P, Graniero GR, Mormino P, Mattarei M, Sanzuol F, Cignacco GB, et al. Prevalence and clinical correlates of microalbuminuria in stage I hypertension. Results from the Hypertension and Ambulatory Record-ing Venetia Study (HARVEST Study). Am J Hypertens 1996; 9: 334–41.
  • Mimran A, Ribstein J, DuCailar G, Halimi J-M. Albuminuria in normals and essential hypertension. J Diabetes Complications 1994; 8: 150–6.
  • Calvino J, Calvo C, Romero R, Gude F, Sanchez-Guisande D. Atherosclerosis profile and microalbumi-nuria in essential hypertension. Am J Kidney Dis 1999; 34: 996–1001.
  • Erley CM, Haefele U, Heyne N, Braun N, Risler T. Microalbuminuria in essential hypertension. Reduction by different antihypertensive drugs. Hypertension 1993; 21: 810–5.
  • Biesenbach G, Zazagomik J. High prevalence of hyper-tensive retinopathy and coronary heart disease in hyper-tensive patients with persistent microalbuminuria under short intensive antihypertensive therapy. Clin Nephrol 1994; 41: 211–8.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.